Skip to main content
← Companies
TLSI

TriSalus Life Sciences, Inc.

Data as of Sep 17, 2026
TLSI
TLSIW
CIK 1826667Surgical & Medical Instruments & Apparatus

Lobbying

$630,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Medicare/Medicaid$630K7 filings

Latest filings, Apr 2025 onward

FiledRegistrant and subjectAmount
Jul 20, 2026
CAPITOL HILL CONSULTING GROUP for TRISALUS LIFE SCIENCES
Medicare/Medicaid Medicare and Medicaid reimbursement issues.
$90,000
Apr 21, 2026
CAPITOL HILL CONSULTING GROUP for TRISALUS LIFE SCIENCES
Medicare/Medicaid Medicare and Medicaid reimbursement issues.
$90,000
Jan 20, 2026
CAPITOL HILL CONSULTING GROUP for TRISALUS LIFE SCIENCES
Medicare/Medicaid Medicare and Medicaid reimbursement issues.
$90,000
Oct 20, 2025
CAPITOL HILL CONSULTING GROUP for TRISALUS LIFE SCIENCES
Medicare/Medicaid Medicare and Medicaid reimbursement issues.
$90,000
Jul 21, 2025
CAPITOL HILL CONSULTING GROUP for TRISALUS LIFE SCIENCES
Medicare/Medicaid Medicare and Medicaid reimbursement issues.
$90,000
Apr 21, 2025
CAPITOL HILL CONSULTING GROUP for TRISALUS LIFE SCIENCES
Medicare/Medicaid Medicare and Medicaid reimbursement issues.
$90,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to TriSalus Life Sciences, Inc. through its SEC registration (CIK 1826667) and tickers TLSI, TLSIW.

As of: lobbying filings through Jul 20, 2026. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.